The small Danish medtech company MagCath is approaching its most comprehensive clinical trial so far and hopes to receive CE marking of its product next year. To finance the trial, the company has joined forces with a group of Danish business angels.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.